Gucci母公司押注，生物制造融资近亿元！

TL;DR - Chinese biomanufacturing startup Daosheng Biotechnology raised nearly RMB 100 million in Pre-A funding to scale biosynthetic indigo production and advance its bio-based pigment platform. The company says it is the first to achieve 100-ton-scale production of indigo using synthetic biology.

• Funding will support commercial-scale indigo production, core technology development, and expansion into additional markets.
• Its portfolio includes biologically produced indigo, melanin, red and yellow pigments, plus active pharmaceutical ingredients.
• Target applications span textiles, food additives, cosmetics, personal care, and pharmaceuticals.
• Daosheng is conducting joint R&D with brands owned by Gucci parent Kering and pursuing projects with international cosmetics and US food companies.